Clinical trial
Non-vitamin K Oral Anticoagulants in Cardioversion of Atrial Fibrillation. FinCV3
NCT02911545 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-vitamin K Oral Anticoagulants in Cardioversion of Atrial Fibrillation. FinCV3
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- May 31, 2016
- Enrollment
- 1,000 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.